Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-04

Clinical Trial Update: Octanol to Treat Essential Tremor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating octanol as a treatment for essential tremor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Octanol (octanol)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED